The report “Next Generation Sequencing (NGS) Market by Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT) & by Application (Diagnostics, Personalized Medicine) – Global Forecast to 2020”, The global NGS market will be worth $2.5 billion by the end of 2014 and is poised to reach $8.7 billion by 2020 at a CAGR of more than 20.0%.
Browse 130 market data tables with 52 figures spread through 242 pages and in-depth TOC on "Next Generation Sequencing (NGS) Market"
Early buyers will receive 10% customization on report.
The next generation sequencing report (2014-2020) covers the market for pre-sequencing, sequencing platforms and bioinformatics tools and services. The NGS pre-sequencing (sample –preparation) segment represents a promising area in the overall market owing to the need for automation and standardized solutions for sample preparation. The market for sequencing platforms has been very dynamic.
Some revolutionary platforms like GA IIx (Illumina) and SOLiD Series (Life Technologies) have taken a setback and newer platforms like HiSeq X Ten, NextSeq 500 and MiSeq are gaining market dominance. The next generation sequencing bioinformatics market comprises of software, workbenches, and services for the interpretation and analysis of data generated by sequencers, representing a lucrative market owing to better user interface and flexibility when compared to open-source tools.
Talk to Our Research Analysts for More Info@
The report also covers the market by applications, including drug discovery, clinical diagnostics, genomics, and proteomics. Along with large research and academic institutions that serve as a key end-user for the next generation sequencing market, NGS technologies are recently being developed for use in clinical set-ups and presently much of the NGS effort is focused on cancer.
The factors driving the next generation sequencing market include decreasing costs, improved turnaround time, increase in number of applications, and replacement of microarray applications by NGS. Personalized medicine and biomarker discovery open avenues for investments, offering huge growth opportunities. However, the causes for hindrance to growth will be the high reliability on grants by research institutes, accuracy and standardization concerns, data storage problems, and issues in interpretation of complex data.
The global next generation sequencing market is geographically segmented into North America, Europe, Asia, and Rest of the World, with North America contributing the highest share, followed by Europe. Government funding, increasing opportunities in NGS clinical applications and presence of dominant NGS platform players in U.S. are the main drivers for the North American market. The Asian next generation sequencing market is expected to grow the fastest owing to its growing presence in the sequencing and NGS bioinformatics services market.
Get The Sample Copy Of This Report:
The key players in the NGS platforms market include Illumina (U.S.), Life Technologies (Thermo Fisher Scientific) (U.S.), 454 Roche (U.S.), and Pacific Biosciences (U.S.). The NGS bioinformatics/data analysis market is dominated by players like CLC bio (Denmark) (acquired by QIAGEN), Biomatters (New Zealand), Partek (U.S.), Genomatix (Germany), Knome (U.S.), and DNASTAR (U.S.).
Browse related reports:
Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018.
Whole Exome Sequencing Market by Product [Systems, Kits (Library Preparation, Target Enrichment)], Services (Sequencing), Technology (Sequencing by Synthesis), & by Application (Cancer, Monogenic disorders) - Global Forecast to 2018.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain@ http://www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets